Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Mohd Haider

Titan Pharmaceuticals Stock Surges 23% After Hours on Stockholder Approval of Three-Way Merger

Physician,And,Patient,Examine,A,Holographic,Dna,Model.,Ai-powered,Genomic

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) closed regular trading at $5.00 per share on Tuesday, before surging 23% to $6.15 in after-hours trading following stockholder approval of a major business combination.

Check out the current price of TTNP stock here. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.